Literature DB >> 16759341

Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.

Bruno Aouizerate1, Ann Ho, James H Schluger, Guillaume Perret, Lisa Borg, Michel Le Moal, Pier V Piazza, Mary Jeanne Kreek.   

Abstract

Combined cocaine and illicit opiate use is common. This study aimed to test the hypothesis that cocaine dependence in former heroin-addicted patients maintained on methadone treatment is associated with enhanced glucocorticoid negative feedback. Multiple dose dexamethasone suppression tests, using a conventional 2.0 mg dose, and two lower doses, 0.5 mg and 0.125 mg, were performed in 10 methadone-maintained former heroin addicts with ongoing cocaine dependence (C-MM), 10 stabilized methadone-maintained former heroin addicts with no ongoing drug or alcohol use (MM), and 22 normal volunteers (NV). At 9 hours, there was no difference in plasma adrenocorticotropin hormone (ACTH) and/or cortisol levels among groups on the baseline day, as well as after the two lower doses of dexamethasone. At 17 hours, C-MM and MM had significantly lower plasma ACTH and/or cortisol levels than NV. However, C-MM did not significantly differ from MM in their hormonal levels. When the hormonal responses to dexamethasone are expressed as magnitude of lowering from baseline, there was no significant difference at any dose among groups. Therefore, C-MM exhibited a normal glucocorticoid negative feedback in the morning. Using the standard interpretation of dexamethasone suppression testing based on the examination of the actual hormonal levels rather than the difference from baseline condition, C-MM appear to have glucocorticoid effects similar to MM, yet were both greater than NV in the late afternoon. Thus, further studies are needed to know whether altered glucocorticoid negative feedback is related to chronic cocaine exposure, or is the result of former heroin addiction and/or its long-term treatment with methadone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759341     DOI: 10.1111/j.1369-1600.2006.00006.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  11 in total

Review 1.  Stress, dysregulation of drug reward pathways, and the transition to drug dependence.

Authors:  George Koob; Mary Jeanne Kreek
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

Review 2.  Role of a functional human gene polymorphism in stress responsivity and addictions.

Authors:  M J Kreek
Journal:  Clin Pharmacol Ther       Date:  2008-03-05       Impact factor: 6.875

3.  Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents.

Authors:  Yan Zhou; Yoav Litvin; Anna Paola Piras; Donald W Pfaff; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2011-06-15       Impact factor: 7.853

Review 4.  Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.

Authors:  Rémi Martin-Fardon; Eric P Zorrilla; Roberto Ciccocioppo; Friedbert Weiss
Journal:  Brain Res       Date:  2009-12-21       Impact factor: 3.252

5.  Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice.

Authors:  Yan Zhou; Rajani Maiya; Erin H Norris; Mary Jeanne Kreek; Sidney Strickland
Journal:  Stress       Date:  2010-07-28       Impact factor: 3.493

Review 6.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

7.  Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals.

Authors:  Kathleen T Brady; Aimee L McRae; Megan M Moran-Santa Maria; Stacia M DeSantis; Annie N Simpson; Angela E Waldrop; Sudie E Back; Mary Jeanne Kreek
Journal:  Arch Gen Psychiatry       Date:  2009-04

Review 8.  Substance abuse, memory, and post-traumatic stress disorder.

Authors:  Megan E Tipps; Jonathan D Raybuck; K Matthew Lattal
Journal:  Neurobiol Learn Mem       Date:  2013-12-15       Impact factor: 2.877

Review 9.  Bidirectional translational research: Progress in understanding addictive diseases.

Authors:  M J Kreek; S D Schlussman; B Reed; Y Zhang; D A Nielsen; O Levran; Y Zhou; E R Butelman
Journal:  Neuropharmacology       Date:  2008-08-07       Impact factor: 5.250

Review 10.  Opioids, dopamine, stress, and the addictions.

Authors:  Mary Jeanne Kreek
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.